LINKER-MM5

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (LINKER-MM5)

Arms / Cohorts

Experimental:Part 1: Arm A

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Part 2: Arm C

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Part 1: Arm B

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Part 2: Arm A

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Part 2: Arm B

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

(888) 850-0650

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.